Next Article in Journal
Inhibitory Effect and Mechanism on Antiproliferation of Isoatriplicolide Tiglate (PCAC) from Paulownia Coreana
Previous Article in Journal
Scope and Limitations of a Novel Synthesis of 3-Arylazonicotinates
Molecules 2012, 17(5), 5935-5944; doi:10.3390/molecules17055935
Article

The Vasorelaxant Mechanisms of a Rho Kinase Inhibitor DL0805 in Rat Thoracic Aorta

1,2
, 1
, 1,* , 1
, 3
, 1
, 1
 and 1,*
Received: 26 March 2012; in revised form: 11 May 2012 / Accepted: 11 May 2012 / Published: 18 May 2012
Download PDF [402 KB, uploaded 18 June 2014]
Abstract: Rho-kinase has been suggested as a potential therapeutic target in the treatment of cardiovascular diseases. The Rho-kinase signaling pathway is substantially involved in vascular contraction. The aim of the present study was to evaluate the vasorelaxant effects of Rho kinase inhibitor DL0805 in isolated rat aortic rings and to investigate its possible mechanism(s). It was found that DL0805 exerted vasorelaxation in a dose-dependent manner in NE or KCl-induced sustained contraction and partial loss of the vasorelaxation under endothelium-denuded rings. The DL0805-induced vasorelaxation was significantly reduced by the nitric oxide synthase inhibitor Nω-nitro-L-arginine methyl ester, the guanylate cyclase inhibitor methylene blue and the cyclooxygenase inhibitor indomethacin. The voltage-dependent K+ channel blocker 4-aminopyridine remarkably attenuated DL0805-induced relaxations. However, the ATP-sensitive K+ channel blocker glibenclamide and Ca2+-activated K+ channel blocker tetraethylammonium did not affect the DL0805-induced relaxation. In the endothelium-denuded rings, DL0805 also reduced NE-induced transient contraction and inhibited contraction induced by increasing external calcium. These findings suggested that DL0805 is a novel vasorelaxant compound associated with inhibition of Rho/ROCK signaling pathway. The NO-cGMP pathway may be involved in the relaxation of DL0805 in endothelium-intact aorta. The vasorelaxant effect of DL0805 is partially mediated by the opening of the voltage-dependent K+ channels.
Keywords: DL0805; vasorelaxation; Rho kinase; aorta; endothelium; nitric oxide DL0805; vasorelaxation; Rho kinase; aorta; endothelium; nitric oxide
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Gong, L.; Peng, J.; Fang, L.; Xie, P.; Si, K.; Jiao, X.; Wang, L.; Du, G. The Vasorelaxant Mechanisms of a Rho Kinase Inhibitor DL0805 in Rat Thoracic Aorta. Molecules 2012, 17, 5935-5944.

AMA Style

Gong L, Peng J, Fang L, Xie P, Si K, Jiao X, Wang L, Du G. The Vasorelaxant Mechanisms of a Rho Kinase Inhibitor DL0805 in Rat Thoracic Aorta. Molecules. 2012; 17(5):5935-5944.

Chicago/Turabian Style

Gong, Lili; Peng, Jianhao; Fang, Lianhua; Xie, Ping; Si, Kun; Jiao, Xiaozhen; Wang, Liping; Du, Guanhua. 2012. "The Vasorelaxant Mechanisms of a Rho Kinase Inhibitor DL0805 in Rat Thoracic Aorta." Molecules 17, no. 5: 5935-5944.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert